DJIA: 16,501.65  -12.72 (-0.08%) | NASDAQ: 4,126.967  -34.491 (-0.83%) | S&P 500: 1,875.39  -4.16 (-0.22%) Markets closed

  • Show Article Details

    Shares of Omnicom Group (OMC) are down -1.99% to $70.07 after CEO John Wren said he was was unable to predict when its $35.1 billion merger with France's Publicis Groupe SA (PGPEF) would close. The deal reportedly hasn't won some key approvals. Yesterday, the advertising agency reported that 2014 first quarter revenue increased 3.0% to $3,502.2 million from $3,398.9 million in the first quarter of 2013.

  • Show Article Details

    By Danielle Robinson Allergan (AGN), the pharma giant behind Botox, saw its bonds plunge some 10 points Tuesday on news that activist investor William Ackman is leading an attempted hostile takeover of the company. Investors said that even an ultimately positive takeover would crush Allergan's A3/A+ investment-grade credit rating, and quickly jumped to market to sell off its paper.

  • Show Article Details

    * Netflix results lift Wall St, deal talk buoys Europe. * Threats of ECB action keeps euro subdued. * Oil prices fall on rising supplies. * U.S. bond prices slip before two-year supply. By Herbert Lash. Global equity markets rose on Tuesday, powered by solid U.S. corporate earnings and deal-making activity among European drugmakers, while the euro edged above break-even.

  • Show Article Details

    LONDON-- U.K. equities advanced Tuesday, with AstraZeneca PLC (AZN) gaining on speculation the British drug maker will receive a takeover bid, while GlaxoSmithKline PLC (GSK) shares rose as the pharmaceutical heavyweight made a couple of its own deals. U.K.' s FTSE 100 index leapt 0.9% to 6,681.76, the highest closing level since April 4, according to data from FactSet, following a four-day break in trading in observance of the Easter holiday. Last week, the index finished the holiday-shortened...

  • Show Article Details

     Lufthansa reiterated Tuesday that the new Oneworld hub in Charlotte won't be a problem for the Star Alliance co-founder, saying its passengers can continue to connect on US Airways."After negotiations with US Airways we are happy that the cooperation with US Airways on our Munich-Charlotte route will continue despite the fact that they are no longer with Star Alliance," said Lufthansa spokesma...

  • Show Article Details

    LONDON-- Drug makers took center stage in European trading Tuesday, with AstraZeneca PLC (AZN) shares posting their best advance in nearly three years on news of a potential takeover bid, and as GlaxoSmithKline PLC (GSK) climbed on the multibillion-dollar sales of a business unit. The Stoxx Europe 600 finished up 1.4% to 337.03 as investors returned from a four-day Easter holiday break to a slate of developments in the pharmaceutical sector, the best-performing group on the pan-European...

  • Show Article Details

    The battle against cancer has taken on a financial dimension, with Novartis (NVS)  agreeing to take a host of oncology drugs from GlaxoSmithKline  in the largest of four multi-billion transactions by the Swiss company, and Pfizer reportedly missing out in a run for AstraZeneca (AZN)  cancer treatments.

  • Show Article Details

    Valeant Pharmaceuticals International (VRX)  and activist investor Bill Ackman on Tuesday revealed the details of their combined hostile effort to acquire Botox-maker Allergan, a move that is the well-known insurgent's first hostile acquisition partnership and one that would bring together two mid-sized pharmaceutical companies if consummated.

  • Show Article Details

    * FTSEurofirst 300 up 1.4 pct, Euro STOXX 50 up 1.3 pct. * Indexes extend gains after strong euro zone consumer confidence. * AstraZeneca jumps 6.3 pct on M&A talk. * Philips drops 5.5 pct after disappointing earnings. By Francesco Canepa.

  • Show Article Details

    Investors love strong earnings, and they love mergers and acquisitions. The Dow was up by 100 points for much of the trading session, but finished with a 65 point gain. Today marks the sixth Tuesday in a row that the Dow has ended the day higher. After the bell, it was a tale of two biotechnology stocks.

  • Show Article Details

    * Lufthansa says in talks with sector heavyweights. * Lufthansa eyes non-binding offers in May. * Deutsche Telekom says not interested. Lufthansa's IT infrastructure business, which the airline is trying to sell, is drawing interest from big IT groups IBM (IBM), Hewlett-Packard (HPQ) and France's Atos, a source familiar with the matter told Reuters.

  • Show Article Details

    U.S. stocks edged up on Tuesday boosted by deals in the healthcare sector and upbeat results, while Facebook and Netflix lifted the Nasdaq. The Dow Jones industrial average rose 21.64 points or 0.13 percent, to 16,470.89, the S&P 500 gained 2.66 points or 0.14 percent, to 1,874.55 and the Nasdaq Composite added 17.603 points or 0.43 percent, to 4,139.149.

  • Show Article Details

    * Says yet to get approval for tax residency in the UK. * Failure to make merger tax-free for investors could break the deal - analyst. * U.S. revenue rises 4 pct at Omnicom (OMC), 5 pct at Interpublic. * Omnicom (OMC) 1st-qtr revenue $3.50 bln vs est $3.48 bln. * Interpublic revenue $1.64 bln vs est $1.60 bln. By Sruthi Ramakrishnan.